ADIL - CIK 0001513525
ADIAL PHARMACEUTICALS, INC. trades as ADIL. This page tracks ADIAL PHARMACEUTICALS, INC. through 533 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| Major company event | 8-K | 2026-05-11 |
| Quarterly report | 10-Q | 2026-05-08 |
| Major company event | 8-K | 2026-04-09 |
| Insider trade | 4 | 2026-04-09 |
| Insider trade | 4 | 2026-04-09 |
| Insider trade | 4 | 2026-04-09 |
| Insider trade | 4 | 2026-04-09 |
The largest companies sharing ADIAL PHARMACEUTICALS, INC.'s SEC industry classification (pharmaceutical preparations).
In its latest fiscal year ADIAL PHARMACEUTICALS, INC. reported a net loss of $7.98M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.